Related Experiment Video
Updated: Jul 11, 2026

11:20
A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
Published on: April 1, 2022
Mitral valve replacement with a pulmonary autograft: initial experience
S S Kabbani1, D N Ross, H Jamil
1Damascus University Cardiovascular Surgical Center, Syria.
The Journal of Heart Valve Disease
|August 26, 1999
Summary
The pulmonary autograft offers a viable alternative for mitral valve replacement, addressing limitations of mechanical prostheses and xenografts. This technique shows excellent early function in patients with rheumatic mitral valve disease.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Biomedical Engineering
Background:
- Mechanical prostheses require lifelong anticoagulation, posing challenges in developing countries.
- Xenografts have limited durability in younger populations, and homografts are not yet established.
- Previous research in 1967 explored autograft concepts for valve replacement.
Purpose of the Study:
- To evaluate the feasibility and efficacy of using a pulmonary autograft for mitral valve replacement.
- To address the limitations of existing prosthetic and homograft options for mitral valve substitution.
Main Methods:
- The Ross procedure was adapted to use an inverted pulmonary autograft within a Dacron conduit for mitral valve replacement.
- The autograft-conduit was sutured to the mitral annulus, with the proximal end attached to the atrial wall.
- Right ventricular outflow reconstruction was performed using homografts or xenografts.
Main Results:
- One patient experienced a fatal cerebrovascular accident, likely due to a misplaced pericardial collar.
- Another patient required autograft replacement due to early bacterial endocarditis.
- Echocardiography demonstrated excellent function of the remaining autografts up to 16 months postoperatively.
Conclusions:
- The pulmonary autograft is presented as a potentially valid option for mitral valve replacement.
- This technique may offer a suitable alternative in specific patient populations and healthcare settings.

